COMPANY PROFILE

AutoGenomics

Explore full profile

Pioneer in developing the automated microarray based multiplexing molecular diagnostic platforms

Vista, United StatesFounded 1999Biotech & Life Sciences

Valuation $0–100M Latest valuation · 2007

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About AutoGenomics

AutoGenomics is a biotechnology company specializing in molecular diagnostics, providing advanced genomic technologies to enhance personalized medicine. The company operates in the healthcare and biotechnology market, serving clients such as hospitals, clinical laboratories, and research institutions. AutoGenomics' business model revolves around the development and commercialization of diagnostic tests that leverage their proprietary technology platform. Revenue is generated through the sale of diagnostic kits, instruments, and related services. The company focuses on offering solutions that enable precise and efficient genetic testing, which aids in the early detection and treatment of various diseases.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 1999
Headquarters: Vista, United States
Employees: 43
Open positions: None listed
Dealroom signal: 72.9/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Oncology, DNA, Genetics and genomics, Genome Engineering, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus: b2b
Links: Website X

Latest news

Press, funding announcements and product moves mentioning AutoGenomics.

See all news

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
DEBT✓Debt	Jan 2013	$170K	—	Undisclosed	—
DEBT✓Debt	Jun 2010	$25M	—	Undisclosed	—

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

AutoGenomics website traffic

Latest recorded traffic for AutoGenomics is 610 monthly website visits, down 56.4% over the last three months. AutoGenomics's team grew 0% over the past year.

Latest monthly visits610 3-month web change-56.4% 1-year team growth0%

Monthly website visitsOct 2017–Jun 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
JIJivanaBiotechnologyRNAi-based cancer therapies using nanoparticle delivery technology	Peoria, United States	Operational	1	$1M	$4M
NENeoDiagnostixNeoDiagnostix is committed to pioneering the field of personalized medicine through cancer genomics	Rockville, United States	Operational
SESentieonEnable Precision Data for Precision Medicine	Mountain View, United States	Operational
BIBillionToOneThe only genetic testing platform that accurately and efficiently detects and measures disease at the molecular level	Menlo Park, United States	Operational
ABApogen BiotechnologiesBiotechnology company focused on the development of a new class of therapeutics	Seattle, United States	Operational
GLGoPath LaboratoriesFully equipped, cap accredited and clia certified anatomic pathology, clinical pathology and molecular diagnostic laboratory	Indianapolis, United States	Operational
VSViatar CTC SolutionsDiagnosis and therapy for circulating tumor cells	Lowell, United States	Operational
GIGigaGenOvercoming Immune Dysregulation to Fight Disease	San Carlos, United States	Acquired